Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d4b90046-484a-41d1-8755-915aa5c40d79&Preview=1 Date 10/27/2011 Company Name Redfin Mailing Address 2025 1st Ave Seattle, WA 98121 Company Description Redfin is the industry’s first online real estate brokerage. Unlike any other real estate site, Redfin lets you buy and sell MLS-listed homes online. You can shop for homes and browse prices using our map-driven home-shopping … Continue reading “Redfin Secures $14,800,000 Series E Financing”
Category: Seattle
Clearwire Shares Go for Another Ride on Word of Latest Sprint Plans
One thing you can say about having Sprint as a majority investor: It’s not boring. Shares of Kirkland, WA-based Clearwire (NASDAQ: [[ticker:CLWR]]) bounced up today after the third-quarter earnings report from Sprint (NYSE: [[ticker:S]]), particularly CEO Dan Hesse’s comments about a possible deal for Clearwire’s as-yet-unbuilt long-term evolution network. As quoted by Forbes’ Eric Savitz, … Continue reading “Clearwire Shares Go for Another Ride on Word of Latest Sprint Plans”
Ignition’s Cameron Myhrvold Joins the Lineup for Mobile Madness NW Dec. 6
We’re adding another name to the already power-packed list of speakers for Mobile Madness Northwest on Dec. 6: Cameron Myhrvold, founding partner at Ignition Partners. And speaking of Mobile Madness, you’ll want to buy your tickets now to get the best deal—the best rate expires today. Cameron knows his way around innovation in the Northwest … Continue reading “Ignition’s Cameron Myhrvold Joins the Lineup for Mobile Madness NW Dec. 6”
Emerald Biostructures Gets 3-Year Extension of UCB Drug Partnership
Emerald Biostructures‘ biggest customer is renewing its contract for another three years, and giving Emerald a piece of the action if it can help lay the foundation for new commercial drugs. Bainbridge Island, WA-based Emerald is announcing today that it has gotten a 3-year extension of its collaboration with UCB, a 3.2-billion-euro company in Belgium … Continue reading “Emerald Biostructures Gets 3-Year Extension of UCB Drug Partnership”
BIO Investor Forum Roundup: Immune Design, Sorbent Therapeutics, Epizyme
The best thing about coming to the BIO Investor Forum in San Francisco every year is the schmoozing with folks from all over the country in one place. The worst thing? There’s not much in the way of breaking news. Oh well, sometimes you gotta do the spade work on a slow news day if … Continue reading “BIO Investor Forum Roundup: Immune Design, Sorbent Therapeutics, Epizyme”
Prometheus Energy Group Receives $10,999,767 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9abf98fe-e093-4b25-9c18-bb1fbca2f949&Preview=1 Date 10/26/2011 Company Name Prometheus Energy Group Mailing Address 8511 154th Ave Ne Building I Redmond, WA 98052 Company Description The combination of these elements is at the core of our company. The timing was perfect for the right technology, resources and global energy situation for our philosophy to not just … Continue reading “Prometheus Energy Group Receives $10,999,767 New Funding”
Brammo Lands $28,000,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dee224e8-630b-41f2-8c14-d364e23b7be3&Preview=1 Date 10/26/2011 Company Name Brammo Mailing Address 550 Clover Lane Ashland, OR 97520 Company Description Brammo is in business for one simple reason – to drive change in the New Energy Economy. Our technically-advanced Enertia plug-in electric motorcycle – which gets up to 45 miles per charge – is the lightweight, … Continue reading “Brammo Lands $28,000,000 Series B Round”
Playmark Opens Digital Licensing Shop with Rights to 2,000 NFL Players
Professional athletes marketing their mugs in endorsements is nothing new. But the explosion of digital goods and micro-entrepreneurs has opened up a ton of new ways for sports stars to make their mark, such as the mobile apps and games from the likes of Chad Ochocinco and Mike Tyson. Seattle startup Playmark is hoping to … Continue reading “Playmark Opens Digital Licensing Shop with Rights to 2,000 NFL Players”
UW Prof’s Startup Rolls out Smart Thermostats, Inspired by Apple’s Iconic Devices
In her work at the University of Washington, Yoky Matsuoka spends time figuring out how to make the brain work directly with machines. In her startup work, she’s targeting something a lot less fancy-sounding: the home thermostat. Matsuoka is vice president of technology at Nest, a Palo Alto, CA-based startup aiming to tackle energy efficiency … Continue reading “UW Prof’s Startup Rolls out Smart Thermostats, Inspired by Apple’s Iconic Devices”
Zaarly Rings Up $14M to Fuel Growth, adds Firepower to Board with HP’s Meg Whitman
Peer-to-peer e-commerce startup Zaarly, born out of a Startup Weekend event just this spring, has tallied a new $14.1 million venture round and is adding freshly installed Hewlett-Packard chief Meg Whitman to its board. The news represents some pretty high-profile votes of confidence in Zaarly, which has only been around as a functioning product for … Continue reading “Zaarly Rings Up $14M to Fuel Growth, adds Firepower to Board with HP’s Meg Whitman”
VisibleBrands Secures $2,000,000 Series A Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6a43bc69-3159-4a65-8b93-8c6348ee7b38&Preview=1 Date 10/25/2011 Company Name VisibleBrands Mailing Address Undisclosed Kirkland, WA 98083 Company Description Shoppers make purchase decisions while they are in the store, in the aisle. The Moment of Decision™ is what matters most, the moment where advertisers can have the most impact with their audience – and deliver the last … Continue reading “VisibleBrands Secures $2,000,000 Series A Financing Round”
Facebook Takes Credits to the Web, & Real’s GameHouse is the Petri Dish
Facebook is testing its virtual currency system, Facebook Credits, on sites across the broader Web—and the first public guinea pig is GameHouse, the casual-games division of RealNetworks (NASDAQ: [[ticker:RNWK]]) that is going full-bore after a bigger slice of the social-gaming sector. Facebook Credits allow players to buy “virtual goods” within games they play. So, if … Continue reading “Facebook Takes Credits to the Web, & Real’s GameHouse is the Petri Dish”
Tippr’s Martin Tobias: Groupon Clones Done, ‘Arms Dealer’ Approach Paying Off
Updated 10:45 am Pacific After Groupon’s season of woe, a truckload of me-too disappearing acts, and last week’s mass-layoff meltdown at third-place competitor BuyWithMe, it sure isn’t looking like a very bullish time to be operating a daily deals startup. Martin Tobias would disagree. The Seattle entrepreneur, who been through some notable ups and downs … Continue reading “Tippr’s Martin Tobias: Groupon Clones Done, ‘Arms Dealer’ Approach Paying Off”
Biotech VCs Have a Problem, and it Will Get Worse Before It Gets Better
We’ve heard warnings for a couple of years now that the chickens would come home to roost in the biotech venture capital scene. Quite a few VCs just haven’t delivered the returns to back up all their talk, and you can’t wait around forever for things to improve. This drama is going to be long … Continue reading “Biotech VCs Have a Problem, and it Will Get Worse Before It Gets Better”
From the Lab that Brought You Siri, It’s Trapit—A Personalized Discovery Engine
There are two kinds of people: Those who already own an iPhone 4S, and those who don’t but have seen Apple’s Siri ads and wish they did. Siri, of course, is the voice-operated personal assistant that can read your text messages, schedule appointments, check on the weather, make waffles, and babysit your toddler (just kidding … Continue reading “From the Lab that Brought You Siri, It’s Trapit—A Personalized Discovery Engine”
Video: What is Cloud Computing, Anyway? These Kids Get Pretty Close
The Seattle area is an undeniable leader in the rapidly growing cloud-computing sector, from tech mega-companies like Microsoft and Amazon, to local branches like the expanding EMC Isilon division, and active investors. We know it’s big. We know it’s important. We know it will change the way things are done. But if you’re not an … Continue reading “Video: What is Cloud Computing, Anyway? These Kids Get Pretty Close”
UW Spinoff Impel NeuroPharma Nabs Two Big Pharma Deals, $500K in Angel Financing
Seattle-based Impel NeuroPharma has gotten a big vote of confidence for its technology that aims to deliver certain drugs more efficiently to the brain. The company, a University of Washington spinout, said today it has secured funding from two of the world’s top 10 pharmaceutical companies, plus another $500,000 in a Series B angel financing. … Continue reading “UW Spinoff Impel NeuroPharma Nabs Two Big Pharma Deals, $500K in Angel Financing”
Analyst: Seattle Genetics on Pace to Smash Wall Street Forecast with Lymphoma Drug Rollout
Seattle Genetics only had 30 full business days in the last quarter to sell its first drug, and at least one analyst says the company nailed the early days of its commercial rollout. The Bothell, WA-based biotech company (NASDAQ: [[ticker:SGEN]]) won FDA approval to start selling brentuximab vedotin (Adcetris) as a new treatment for Hodgkin’s … Continue reading “Analyst: Seattle Genetics on Pace to Smash Wall Street Forecast with Lymphoma Drug Rollout”
How the iPhone Got Tail Fins—Part 2 of 2
Read part 1 of this post for background. By the early 1920s General Motors realized that Ford, which was now selling the Model T for $290, had an unbeatable monopoly on low-cost automobile manufacturing. Other manufacturers had experimented with selling cars based on an image and brand. (The most notable was an ad by the … Continue reading “How the iPhone Got Tail Fins—Part 2 of 2”
Illumina Leads $8M Investment in GenoLogics to Help Manage DNA Data Overload
San Diego-based Illumina, the world’s leading maker of gene sequencing instruments, is getting more serious about software as its customers continue to drown in a sea of cheap DNA data. Victoria, BC-based GenoLogics is announcing today it has raised $8 million in what it called a “strategic financing” led by Illumina (NASDAQ: [[ticker:ILMN]]), the world’s … Continue reading “Illumina Leads $8M Investment in GenoLogics to Help Manage DNA Data Overload”
Xconomist of the Week: Joe Chung Says Redstar Ventures Is Creating Companies for “the TechCrunch Crowd’s Mothers”
“There’s sort of an infinite number of good ways to start a company,” says Xconomist Joe Chung. “One of the fundamental rules in startups is that there really aren’t any rules.” But the serial entrepreneur has some pretty specific plans for how his new creation will pop out startups. That would be Cambridge, MA-based Redstar … Continue reading “Xconomist of the Week: Joe Chung Says Redstar Ventures Is Creating Companies for “the TechCrunch Crowd’s Mothers””
Amgen Cuts 70 Washington Jobs, Hutch Spins Off Blaze Bioscience, Henney Enters the Hall, & More Seattle-Area Life Sciences News
Chronically bad unemployment is the biggest story in the U.S. today, and we had some more bad news about jobs being lost this week in Seattle biotech. But there were a few other good things to report, including a story about a new company being born. —Amgen (NASDAQ: [[ticker:AMGN]]), the Thousand Oaks, CA-based biotech giant, … Continue reading “Amgen Cuts 70 Washington Jobs, Hutch Spins Off Blaze Bioscience, Henney Enters the Hall, & More Seattle-Area Life Sciences News”
Inrix, Zulily Battle for Top Spot in WA’s Q3 Venture Dollars
Microsoft traffic-data spinout Inrix and flash-sales startup Zulily led the field of Washington state-based companies raising venture capital in the third quarter, which yielded $192.5 million across 27 deals, according to the latest MoneyTree Report from the National Venture Capital Association and PriceWaterhouseCoopers. Inrix‘s $37 million expansion round made news in late July. CEO Bryan … Continue reading “Inrix, Zulily Battle for Top Spot in WA’s Q3 Venture Dollars”
Mobile Madness Northwest
Join Xconomy for Mobile Madness Northwest, a lively afternoon conference and networking reception, presented in partnership with the Washington Technology Industry Association. In a series of interactive talks and chats, you’ll hear stories from some of the top companies, entrepreneurs, and investors working to shape the future of mobile innovation in the region, as well … Continue reading “Mobile Madness Northwest”
EMC Isilon Adding 200 Jobs at Seattle Hub, Already Outgrowing New Offices
Big-data company EMC plans to add 200 jobs at its Seattle-based Isilon branch through 2012, filling out spacious new offices in the city’s Pioneer Square neighborhood—and leading to another hunt for office space in the not-too-distant future. Add those 200 new jobs to the 430 Isilon workers already in Seattle, and some additional people from … Continue reading “EMC Isilon Adding 200 Jobs at Seattle Hub, Already Outgrowing New Offices”
Amgen Confirms 380 Layoffs in R&D; Cuts Coming to Seattle, SF, Boston
Word came out of Amgen last week that it was looking to overhaul its R&D operations, and today the biotech giant confirmed the overhaul is translating into job cuts for 380 people across the company. Thousand Oaks, CA-based Amgen (NASDAQ: [[ticker:AMGN]]) notified 380 employees internally today that their jobs are being eliminated as part of … Continue reading “Amgen Confirms 380 Layoffs in R&D; Cuts Coming to Seattle, SF, Boston”
Got Some Immunex Memorabilia in the Closet? Break it Out at the Immunex Impact Dec. 1
If you ever worked at Immunex, chances are you got a T-shirt, pen, coffee mug or some other piece of swag with a logo on it. The stuff might have been shipped off to Goodwill a long time ago, but if it’s still sitting there in the closet, I have an idea for what you … Continue reading “Got Some Immunex Memorabilia in the Closet? Break it Out at the Immunex Impact Dec. 1”
GSK Malaria Vaccine Stands Out at Gates Foundation Confab, But Cost Still the Big Question
The buzz at the Bill & Melinda Gates Foundation’s malaria conference yesterday was all about clinical trial results from a new vaccine the foundation developed with pharma giant GlaxoSmithKline. But there’s a big question about how much this vaccine will cost, and nobody is willing to offer specifics about that yet. To recap, here’s what … Continue reading “GSK Malaria Vaccine Stands Out at Gates Foundation Confab, But Cost Still the Big Question”
MoneyTree Report Sees Third-Quarter Slowdown in U.S. Venture Investments
Venture capital firms invested $6.95 billion in 876 deals throughout the United States during the three months that ended Sept. 30, according to the MoneyTree Report by PricewaterhouseCoopers and the National Venture Capital Association. The numbers marked a slowdown from the preceding quarter, when venture capitalists put $7.9 billion in 1,015 deals. But look at … Continue reading “MoneyTree Report Sees Third-Quarter Slowdown in U.S. Venture Investments”
Mobile Madness, VC Dollars, Appature’s Growth: Wrapping up Seattle’s Tech Headlines
The biggest news out of Xconomy Seattle this past week is the announcement of Mobile Madness NW, our December 6 half-day forum presented with the Washington Technology Industry Association and hosted by F5 Networks. We’ve got a stellar lineup of speakers, including Wesley Chan from Google Ventures, Tom Alberg from Madrona Venture Group, Bernie Yee from Bungie … Continue reading “Mobile Madness, VC Dollars, Appature’s Growth: Wrapping up Seattle’s Tech Headlines”
How the iPhone Got Tail Fins—Part 1 of 2
It was the most advanced consumer product of the century. The industry started with its innovators located in different cities over a wide region. But within 20 years it would be concentrated in a single entrepreneurial startup cluster. At first it was a craft business, then it was driven by relentless technology innovation and then … Continue reading “How the iPhone Got Tail Fins—Part 1 of 2”
Blaze Bioscience, Fred Hutch Spinoff with Zymo Vet at the Helm, Seeks to “Paint” Tumors
Heather Franklin had a lot to think about in September 2010. She was a senior vice president at Seattle-based ZymoGenetics, when it agreed to be acquired by Bristol-Myers Squibb for $885 million. Now that the big company was calling the shots, it was time to think about a new move in her career. Jim Olson, … Continue reading “Blaze Bioscience, Fred Hutch Spinoff with Zymo Vet at the Helm, Seeks to “Paint” Tumors”
EquaShip Starts Challenging FedEx, UPS with Big Discounts for the Little Guy
When two million online merchants fire up their shipping software today, they’ll see a fourth option for package carriers: EquaShip, a Seattle startup aiming to take on FedEx and UPS by offering steep discounts for small and medium-sized businesses. We first profiled EquaShip back in March, when it was known under a different name. Since … Continue reading “EquaShip Starts Challenging FedEx, UPS with Big Discounts for the Little Guy”
Cozi Group Garners $2,469,922 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bb634cd7-8b5e-46b3-842c-7bad078dfbca&Preview=1 Date 10/18/2011 Company Name Cozi Group Mailing Address 506 Second Avenue Seattle, WA 98104–2328 Company Description Cozi delivers a new type of service called family-ready software services. These are created specifically with family dynamics in mind, with an emphasis on making life easier, less stressful and more fun for busy families. … Continue reading “Cozi Group Garners $2,469,922 New Round”
Mobile Madness NW: Xconomy and WTIA Join Forces for an All-Star Forum Dec. 6
The region that pioneered national wireless networks is at a turning point. Carriers are heading toward more consolidation, piling up tons of user data, and scrambling to build their next-generation networks. Microsoft is battling to be the vital third competitor in mobile operating systems, while Amazon stakes out its own device and cloud services ecosystem … Continue reading “Mobile Madness NW: Xconomy and WTIA Join Forces for an All-Star Forum Dec. 6”
Video: Microsoft Research, CMU Take Covers off “OmniTouch” Touchscreen Projector
We got a look at one of Microsoft Research’s latest advanced-interface projects a few weeks back, during festivities for MSR’s 20th anniversary. The company actually prohibited anyone from taking images of one demo in particular, for a projected-touchscreen system called OmniTouch, just because the team was going to present it at an upcoming conference. Well, … Continue reading “Video: Microsoft Research, CMU Take Covers off “OmniTouch” Touchscreen Projector”
Chris Henney, the Immunex and Dendreon Mover/Shaker, Makes Biotech Hall of Fame
Christopher Henney, the immunologist who co-founded three of Seattle’s most successful biotech companies from the past 30 years, has made it into the industry’s Hall of Fame. Henney, 70, was given the Hall of Fame award for outstanding individual contributions to biotech at the annual Biotech CEO Meeting in Laguna Beach, CA. He’s currently the chairman … Continue reading “Chris Henney, the Immunex and Dendreon Mover/Shaker, Makes Biotech Hall of Fame”
Marina Biotech Finds $15M From Investor to Keep Pursuing RNAi Drugs
Marina Biotech has found a way to extend its runway a little longer, by finding a single investor willing to pump in another $15 million. The Bothell, WA-based company (NASDAQ: [[ticker:MRNA]]), the developer of RNA interference drugs, said today in a regulatory filing that Lincoln Park Capital Fund has agreed to invest as much as … Continue reading “Marina Biotech Finds $15M From Investor to Keep Pursuing RNAi Drugs”
Putting Consumer Reviews to Work: PowerReviews Takes on Amazon, Looks to “Social Navigation” for E-Retailers
If you’re like me, you do a lot of research online before you make a big buying decision, and sometimes even before a small one. And you lean heavily on the reviews left by other shoppers. My favorite trick, when I’m zeroing in on a specific product, is to read all of the “1 star” … Continue reading “Putting Consumer Reviews to Work: PowerReviews Takes on Amazon, Looks to “Social Navigation” for E-Retailers”
Mobisante Sees Early Demand for Ultrasound on a Smartphone, Before It’s Really Ready to Roll
The folks at Redmond, WA-based Mobisante have what entrepreneurs sometimes call a “high-class problem.” The startup is getting more attention for its ultrasound-on-a-smartphone product than it really wants in its infancy. Mobisante, a startup founded in 2007, started turning heads back in February, after Xconomy reported that it was the first company to win FDA … Continue reading “Mobisante Sees Early Demand for Ultrasound on a Smartphone, Before It’s Really Ready to Roll”
Genomics 2.0: Ten Years After the Bubble, it’s Getting Really Interesting Again
What do 10,000 people with autism, 50,000 people in some remote islands in the North Atlantic, and 1,000 healthy old folks in southern California have in common? They are on the front edge of one of the most exciting stories in science today, and their contributions will have a huge impact on our long-term understanding … Continue reading “Genomics 2.0: Ten Years After the Bubble, it’s Getting Really Interesting Again”
iCal or iHAL? Apple and the Terrible, Horrible, No Good, Very Bad Day
Dear Mom: You asked me to write to let you know if I arrived safely in iCloud-land. Well, I’m here and I’m in one piece, although unfortunately some of my things didn’t make it here with me, such as my calendar. It was a pretty hellish journey, I’ll tell you. There were a couple of … Continue reading “iCal or iHAL? Apple and the Terrible, Horrible, No Good, Very Bad Day”
Xconomist of the Week: Appature’s Kabir Shahani Eyes Culture as Company Expands
When it’s time for a scrappy tech startup with a bootstrapped culture to expand its footprint, the conventional thinking might go something like this: Hire young, hungry people who won’t blow through too much of your coin, and hold onto that staff until you absolutely have to take the plunge into grown-up salaries and benefits. … Continue reading “Xconomist of the Week: Appature’s Kabir Shahani Eyes Culture as Company Expands”
Greenpeace and Michele Bachmann’s Joint Campaign to Stop Science
I took the family to Boston on vacation in September. During the time away, I read Patrick Moore’s book “Confessions of a Greenpeace Dropout: The Making of a Sensible Environmentalist.“ Dr. Moore was one of the original founders of Greenpeace in the 1970s. I heard him speak recently. While he remains a passionate advocate for … Continue reading “Greenpeace and Michele Bachmann’s Joint Campaign to Stop Science”
Pathway Medical’s Future in Seattle Uncertain as Bayer’s Medrad Lets Lease Option Expire
Pathway Medical Technologies, the Kirkland, WA-based medical device company acquired in August for $125 million by Bayer’s Medrad unit, is sending signs that it may soon be leaving the Northwest. Pathway currently has a lease on a 50,000 square foot facility, with room for its 170 employees, in Kirkland. Pathway’s lease on the building extends … Continue reading “Pathway Medical’s Future in Seattle Uncertain as Bayer’s Medrad Lets Lease Option Expire”
Patricia Beckmann, Co-Inventor of Enbrel, to Join “The Immunex Impact” Dec. 1
Patricia Beckmann has covered lots of bases in biotech—science, venture capital, entrepreneurship, and state officialdom. But once an Immunoid, always an Immunoid. So I’m excited to have her join Xconomy as one of the speakers at our next big Seattle life sciences event, “The Immunex Impact,” on Dec. 1. For those who may have lost … Continue reading “Patricia Beckmann, Co-Inventor of Enbrel, to Join “The Immunex Impact” Dec. 1″
Amgen Mulls R&D Cuts, Thong Le Named WBBA Chairman, NanoString’s Version 2.0, & More Seattle-Area Life Sciences News
The Seattle biotech community got an energetic new leader this week, but there was also some more grim news about budget cuts coming at one of the biggest local life sciences employers. —Amgen (NASDAQ: [[ticker:AMGN]]), the Thousand Oaks, CA-based biotech giant, is looking to “improve focus” and “re-allocate resources” in its $2.9 billion R&D budget, … Continue reading “Amgen Mulls R&D Cuts, Thong Le Named WBBA Chairman, NanoString’s Version 2.0, & More Seattle-Area Life Sciences News”
VC Keeps up Hot Pace, 2011 Could Mark 10-Year Peak, CB Insights Says
Market meltdowns, international turmoil, stubborn unemployment—none of the lingering macro-economic troubles seem to be holding back the momentum for venture investing in 2011, according to a report on third-quarter investments from research firm CB Insights. The latest tally from the firm’s venture capital database shows venture investments reaching $7.9 billion in the quarter across 790 … Continue reading “VC Keeps up Hot Pace, 2011 Could Mark 10-Year Peak, CB Insights Says”
InEnTec Receives $22,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=729ee286-7fe6-462d-86b2-d2c9c2203ada&Preview=1 Date 10/13/2011 Company Name InEnTec Mailing Address 595 SW Bluff Drive Bend, OR 97702 Company Description InEnTec’s technology, called the Plasma Enhanced Melter or PEM, uses the power of plasma to break materials apart into their elemental components (such as hydrogen, carbon, and oxygen) and then transform those elements into synthesis … Continue reading “InEnTec Receives $22,000,000 New Funding Round”
Amgen Looking to Improve Focus and “Re-allocate Resources” for R&D, Say More Oct. 24
Amgen, the world’s largest biotechnology company, just sent a signal to its staff that cuts could be coming soon to its R&D operations. Amgen (NASDAQ: [[ticker:AMGN]]) is based in Thousand Oaks, CA, and has R&D operations in Seattle, South San Francisco, and Cambridge, MA. News of potential cuts to Amgen’s R&D operations were reported earlier … Continue reading “Amgen Looking to Improve Focus and “Re-allocate Resources” for R&D, Say More Oct. 24″